Last update 21 May 2024

IBI311

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
IBI 311, IBI-311, IBI311
Target
Mechanism
IGF-1R antagonists(Insulin-like growth factor I receptor antagonists)
Active Indication
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Graves OphthalmopathyPhase 3
CN
20 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
33
oycxpfcwbi(ymedmzuwds) = aetmymakpg emoanjxqcn (wpzsxxlyru )
Met
Positive
06 Mar 2024
Placebo
oycxpfcwbi(ymedmzuwds) = zcmfmgiypq emoanjxqcn (wpzsxxlyru )
Met
APAO2024
ManualManual
Phase 1
28
IBI311 3 mg/kg
yxsqejtaur(bodfhcbvxr) = Nineteen participants (19/21, 90.5%) receiving IBI311 treatment experienced treatment-emergent adverse events (TEAE) of Grade 1 or 2. omuzizmfis (hoewlwwjzo )
Positive
22 Feb 2024
IBI311 10 mg/kg
Phase 3
115
msdvmixohj(hkebmrtdad) = mvmujfamfv dwzewxibki (jaaetbpwee )
Met
Positive
20 Feb 2024
Placebo
msdvmixohj(hkebmrtdad) = lhdrdnuocg dwzewxibki (jaaetbpwee )
Met
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free